SCHEMBL25325933

SCHEMBL25325933

COCn1cnc(Br)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30756133 0.80 HDAC1 (0.40)
SCHEMBL20320471 0.77
SCHEMBL17686510 0.75
SCHEMBL28762930 0.72
SCHEMBL25437531 0.71 HDAC1 (0.31)
SCHEMBL25437529 0.71 HDAC1 (0.31)
SCHEMBL7816611 0.71 HDAC1 (0.41)
SCHEMBL4672515 0.68 NOTUM (0.44)
SCHEMBL30685417 0.68
SCHEMBL28301203 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250099448-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2025-03-27 US disclosed
CN-119233971-A Pyridazine compound, preparation method and application thereof 上海华汇拓医药科技有限公司 2024-12-31 CN disclosed
EP-4469446-A1 NEW HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2024-12-04 EP disclosed
WO-2023144160-A1 NEW HETEROCYCLIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2023-08-03 WO disclosed